References
- FonsecaDEKlineJNUse of CpG oligonucleotides in treatment of asthma and allergic diseaseAdv Drug Deliv Rev20096125626219167442
- SalemAKWeinerJGCpG oligonucleotides as immunotherapeutic adjuvants: innovative applications and delivery strategiesAdv Drug Deliv Rev20096119319419166888
- VollmerJKreigAMImmunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonistsAdv Drug Deliv Rev20096119520419211030
- ZhouSKawakamiSYamashitaFHashidaMIntranasal administration of CpG DNA lipoplex prevents pulmonary metastasis in miceCancer Lett2010287758119660857
- HornungVRothenfusserSBritschSQuantitative expression of Toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligonucleotidesJ Immunol20021684531453711970999
- WeinerGJLiuHMWooldridgeJEDahleCEKriegAMImmunostimulatory oligonucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunizationProc Natl Acad Sci U S A19979410833108379380720
- BauerSKirschningCJHackerHHuman TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognitionProc Natl Acad Sci U S A2001989237924211470918
- VerthelyiDIshiiKJGurselMTakeshitaFKlinmannDMHuman peripheral blood cells differentially recognize and respond to two distinct CpG motifsJ Immunol20011662372237711160295
- KerkmannMCostaLTRichterCSpontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-α induction by CpG-A in plasmacytoid dendritic cellsJ Biol Chem20052808086809315591070
- KleinDCGLatzEEspevikTStokkeBTHigher order structure of short immunostimulatory oligonucleotides studied by atomic force microscopyUltramicroscopy201011068969320202756
- KrugARothenfusserSHornungVIdentification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cellsEur J Immunol2001312154216311449369
- KriegAMCpG motifs in bacterial DNA and their immune effectsAnnu Rev Immunol20022070976011861616
- GürselMVerthelyiDGürselIIshiiKJKlinmanDMDifferential and competitive activation of human immune cells by distinct classes of CpG oligonucleotideJ Leukoc Biol20027181382011994506
- HartmannGWeeratnaRDBallasZKDelineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivoJ Immunol20001641617162410640783
- HartmannGKriegAMMechanism and function of a newly identified CpG DNA motif in human primary B cellsJ Immunol200016494495310623843
- KrugATowarowskiABritschSToll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 lignd to induce high amount of IL-12Eur J Immunol2001313026303711592079
- SheehanJPLanHCPhosphorothioate oligonucleotides inhibit the intrinsic tenase complexBlood199892161716259716589
- BrownDAKangSHGryaznovSMEffect of phosphorothioate modification of oligodeoxy-nucleotides on specific protein bindingJ Biol Chem199426926801268057929417
- LevinAAA review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense of oligonucleotidesBiochim Biophys Acta19991489698410806998
- HenrySPBeattieGYehGComlement activation is responsible for acute toxicities in rhesus monkeys treated with a phosphorothioate oligonucleotideInt Immunopharmacol200221657166612469940
- MengWYamazakiTNishidaYHanagataNNuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonistsBMC Biotechnol201111889621943407
- ZhuYMengWLiXGaoHHanagataNDesign of mesoporous silica/cytosine-phosphodiester-guanin oligodeoxynucleotide complexes to enhance delivery efficiencyJ Phys Chem C2011115447452
- ZhiCMengWYamazakiTBN nanospheres as CpG ODN carriers for activation of toll-like receptor 9J Mater Chem20112152195222
- WilsonKDSusanDJTamYKLipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacyAdv Drug Deliv Rev20096123324219232375
- BourquinCAnzDZwiorekKTargeting CpG oligonucleotides to the lymph node by nanoparticles elicits efficient antitumoral immunityJ Immunol20081812990299818713969
- KuramotoYKawakamiSZhouSFukudaKYamashitaFHashidaMUse of mannosylated cationic liposomes/immunostimulatory CpG DNA complex for effective inhibition of peritoneal dissemination in miceJ Gene Med20081039239918181219
- ChenXWuPRousseasMBoron nitride nanotubes are noncytotoxic and can be functionalized for interaction with proteins and cellsJ Am Chem Soc200913189089119119844
- XiaTKovochichMLiongMPolyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructsACS Nano200933273328619739605
- HomCLuJLiongMMesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cellsSmall201061185119020461725
- ChenAMZhangMWeiDCo-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resisitant cancer cellsSmall200952673267719780069
- JiQGuoCYuXFlake-shell capsules: adjustable inorganic structuresSmall572012 [Epub ahead of print.]
- ParkIYKimIYYooMKChoiYJChoMHChoCSMannosylated polyethyleneimine coupled mesoporous silica nanoparticles for receptor-mediated gene deliveryInt J Pharm200835928028718490119
- ElbakryAZakyALieblRRachelRGeopferichABreunigMLayer-by-layer assembled gold nanoparticles for siRNA deliveryNano Lett200992059206419331425
- McBainSCYiuHHPHajAEDobsonJPolyethyleneimine functionalized iron oxide nanoparticles as agents for DNA delivery and transfectionJ Mater Chem20071725612565
- ZhuYMengWHanagataNCytosine-phosphodiester-guanin oligodeoxynucleotide (CpG ODN)-capped hollow mesoporous silica particles for enzyme-triggered drug deliveryDalton Trans201140102031020821901222
- ZhuYMengWGaoHHanagataNHollow mesoporous silica/poly(Llysine) particles for codelivery of drug and gene with enzyme-triggered release propertyJ Phys Chem C20111151363013636
- FischerDBieberTLiYXElsasserHPKisselTA novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicityPharm Res1999161273127910468031
- GodbeyWTWuKKMikosAGSize matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicleJ Biomed Mater Res19994526827510397985
- KunathKvon HarpeAFischerDLow-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimineJ Control Release20038911312512695067
- WangCFLinYXJiangTHeFZhuoRXPolyethylenimine-grafted polycarbonates as biodegradable polycations for gene deliveryBiomaterials2009304824483219539366
- GodbeyWTWuKKMikosAGTracking the intracellular path of poly(ethylenimine)/DNA complexes for gene deliveryProc Natl Acad Sci U S A1999965177518110220439
- BoussifOLezoualc’hFZantaMAA versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimineProc Natl Acad Sci U S A19959272797301
- SonawaneNDSzokaFCVerkmanASChloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNAJ Biol Chem2003278448264483112944394
- HaenslerJSzokaFCPolyamidoamine cascade polymers mediate efficient transfection of cells in cultureBioconjug Chem199343723798274523
- BehrJPGene transfer with synthetic cationic amphiphiles: prospects for gene therapyBioconjug Chem199453823897849066
- PetersenHKunathKMartinALStar-shaped poly(ethylene glycol)-block-polyethylenimine copolymers enhance DNA condensation of low molecular weight polyethyleniminesBiomacromolecules2002392693612217037
- SunCTangTUludagHCuervoJEMolecular dynamics simulations of DNA/PEI complexes: Effect of PEI branching and protonation stateBiophys J20111002754276321641321